Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mamons
    Member
    • Nov 2011
    • 10

    #1

    VCF to BED, problems with multi allelic calls

    I'm trying to convert VCF to BED, loosing as little information as possible, but the closer I look the more problems arise.

    A simple heterozygote SNP is not a problem (Skipped some information for readability):

    VCF
    #CHROM POS ID REF ALT QUAL FILTER INFO FORMAT IND_1 Ind_2
    1 209949474 rs41303065 G A 4448.64 PASS AC=1;... GT:... 0/1:... 0/0:...

    is converted to

    BED
    #Chrom Start Stop Ref Alt ID FORMAT Ind_1 Ind_2
    1 209949474 209949474 G A rs41303065 GT:... 0/1:... 0/0:...

    A multiallelic call should be split into the same number of rows as there are alternatives?
    At least this is the way that the well used convert2annovar.pl does it. We have:

    VCF
    #CHROM POS ID REF ALT QUAL FILTER INFO FORMAT IND_1 Ind_2
    1 209969979 rs5780538 A AAC,AACAC 1556.66 PASS AC=2,0;... GT:... 0/1:... 1/2:...

    BED
    #Chrom Start Stop Ref Alt ID FORMAT Ind_1 Ind_2
    1 209969980 209969982 - AC rs41303065 GT:... 0/1:... 1/2:...
    1 209969980 209969984 - ACAC rs41303065 GT:... 0/1:... 1/2:...

    My questions are:

    Is the dbSNP-ID relevant for all alternatives in one position?
    How do we preserve the genotype call here?
    Individual 1 is genotyped A/AC and individual 2 AAC/ACAC, how do we show this when the call is split?
    If we want to annotate the frequency of this variant by using some frequency database, will the different alternatives get different frequencies?

    I know that most people skip these positions since it is most likely that we have false positives when multiallelic calls, I would really like to not skip things without closer examination.

    We learn from GATK that the larger number of individuals called simultaneously the better quality our call set will have, also the more multiallelic calls we will see.
    So when annotating our callset for future analysis it is importans that these calls can be handeled.

    I really hope that some of you can contribute with some ideas and solutions.

    Best regards,

    Måns

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...